Cancers · 2014 · 72 citations · 33 references
MedicineOncologyRadiation OncologyClinical Radiation OncologySurgical OncologyTreatment PlanningEsophageal CancerIntensity-modulated RadiotherapyProton TherapyRadiation TherapyRadiation Treatment PlanningThree-dimensional Conformal Radiotherapy3D-conformal RadiotherapyCardiopulmonary ComplicationsConcurrent Chemoradiation TherapyEsophageal Cancer PalliationIntensity Modulated Radiation Therapy Dose CalculationIntensity-modulated Radiation Therapy DosimetryNeoadjuvant ChemoradiotherapyNeoadjuvant Concurrent Chemoradiation
Background. While neoadjuvant concurrent chemoradiotherapy has improved outcomes for esophageal cancer patients, surgical complication rates remain high. The most frequent perioperative complications after trimodality therapy were cardiopulmonary in nature. The radiation modality utilized can be a strong mitigating factor of perioperative complications given the location of the esophagus and its proximity to the heart and lungs. The purpose of this study is to make a dosimetric comparison of Intensity-Modulated Radiation Therapy (IMRT), proton and 3D conformal radiotherapy (3D-CRT) with regard to reducing perioperative cardiopulmonary complications in esophageal cancer patients. Materials. Ten patients with esophageal cancer treated between 2010 and 2013 were evaluated in this study. All patients were simulated with contrast-enhanced CT imaging. Separate treatment plans using proton radiotherapy, IMRT, and 3D-CRT modalities were created for each patient. Dose-volume histograms were calculated and analyzed to compare plans between the three modalities. The organs at risk (OAR) being evaluated in this study are the heart, lungs, and spinal cord. To determine statistical significance, ANOVA and two-tailed paired t-tests were performed for all data parameters. Results. The proton plans showed decreased dose to various volumes of the heart and lungs in comparison to both the IMRT and 3D-CRT plans. There was no difference between the IMRT and 3D-CRT plans in dose delivered to the lung or heart. This finding was seen consistently across the parameters analyzed in this study. Conclusions. In patients receiving radiation therapy for esophageal cancer, proton plans are technically feasible while achieving adequate coverage with lower doses delivered to the lungs and cardiac structures. This may result in decreased cardiopulmonary toxicity and less morbidity to esophageal cancer patients.
33
Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text
Distribution of Coronary Artery Stenosis After Radiation for Breast Cancer
Greger Nilsson, Lars Holmberg, Hans Garmo et al. · Journal of Clinical Oncology · 2011 · 386 citations · Full text